hsp72 preserves muscle function slows progression severe muscular dystrophy
duchenne muscular dystrophy dmd severe progressive muscle wasting disorder caused mutations dystrophin gene result absence membrane-stabilizing protein dystrophin- dystrophin-deficient muscle fibres fragile susceptible influx ca2+ activates inflammatory muscle degenerative pathways- present cure dmd existing therapies ineffective show increasing expression intramuscular heat shock protein hsp72 preserves muscle strength ameliorates dystrophic pathology two mouse models muscular dystrophy treatment bgp pharmacological inducer hsp72 currently clinical trials diabetes improved muscle architecture strength contractile function severely affected diaphragm muscles mdx dystrophic mice dko mice phenocopy dmd results severe spinal curvature kyphosis muscle weakness premature death bgp decreased kyphosis improved dystrophic pathophysiology limb diaphragm muscles extended lifespan found sarcoplasmic/endoplasmic reticulum ca2+-atpase serca main protein responsible removal intracellular ca2+ dysfunctional severely affected muscles mdx dko mice hsp72 interacts serca preserve function conditions stress ultimately contributing decreased muscle degeneration seen hsp72 upregulation treatment bgp similarly increased serca activity dystrophic skeletal muscles results provide evidence increasing expression hsp72 muscle administration bgp- significant therapeutic potential dmd related conditions either self-contained therapy adjuvant potential treatments including gene cell pharmacological therapies
